Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of noiiglutide injection in adults with inadequately controlled type 2 diabetes mellitus on metformin with or without another oral antidiabetic drug
CTR20243773Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of noiiglutide in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Nov 2024; status: completed.
02
Drugs
noiiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20243773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243773.